Literature DB >> 20422196

The diagnosis and treatment of subependymal giant cell astrocytoma combined with tuberous sclerosis.

Tao Jiang1, Ge Jia, ZhenYu Ma, ShiQi Luo, YuQi Zhang.   

Abstract

BACKGROUND: Subependymal giant cell astrocytoma develops in a small proportion of tuberous sclerosis patients. There are still several controversies on the early diagnosis of the tumor, treatment of hydrocephalus, and timing of operation, etc.
METHODS: From September 1996 to April 2006, 17 patients were admitted in neurosurgical department of "Beijing Tiantan Hospital". The authors analyzed medical records and followed up every case.
RESULTS: There are 18 tumors out of 17 patients. One patient had double tumors. Sixteen patients except one underwent tumor resection 17 times. Fifteen tumors out of 17 were gross totally removed; two were partially removed. One patient died of brain infarction postoperatively. Three out of 13 patients with preoperative hydrocephalus still needed ventriculoperitoneal shunt after tumor resection. There was no recurrence after total resection.
CONCLUSION: Diagnosis of tumor should be made by clinical criteria. Serial follow-up is essential for a suspected perimonro lesion to find tumor growth earlier. When there is growth, tumor should be removed as soon as possible. Hydrocephalus will resolve in most cases after tumor resection, while external drainage is suitable for emergent cases. Transcallosal and transcortical approaches are both effective to resect the tumor. Tumor will not recur after total removal.

Entities:  

Mesh:

Year:  2010        PMID: 20422196     DOI: 10.1007/s00381-010-1159-1

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  35 in total

1.  Tuberous sclerosis complex and its founders.

Authors:  F E Jansen; O van Nieuwenhuizen; A C van Huffelen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-05       Impact factor: 10.154

Review 2.  The tuberous sclerosis complex.

Authors:  Peter B Crino; Katherine L Nathanson; Elizabeth Petri Henske
Journal:  N Engl J Med       Date:  2006-09-28       Impact factor: 91.245

3.  On the treatment of subependymal giant cell astrocytomas and associated hydrocephalus in tuberous sclerosis.

Authors:  C Di Rocco; A Iannelli; E Marchese
Journal:  Pediatr Neurosurg       Date:  1995       Impact factor: 1.162

4.  Efficacy of a rapamycin analog (CCI-779) and IFN-gamma in tuberous sclerosis mouse models.

Authors:  Laifong Lee; Paul Sudentas; Brian Donohue; Kirsten Asrican; Aelaf Worku; Victoria Walker; Yanping Sun; Karl Schmidt; Mitchell S Albert; Nisreen El-Hashemite; Alan S Lader; Hiroaki Onda; Hongbing Zhang; David J Kwiatkowski; Sandra L Dabora
Journal:  Genes Chromosomes Cancer       Date:  2005-03       Impact factor: 5.006

5.  Subependymal giant cell astrocytoma. Significance and possible cytogenetic implications of an immunohistochemical study.

Authors:  J M Bonnin; L J Rubinstein; S C Papasozomenos; P J Marangos
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

6.  Mechanisms of unexpected death in tuberous sclerosis.

Authors:  R W Byard; P C Blumbergs; R A James
Journal:  J Forensic Sci       Date:  2003-01       Impact factor: 1.832

Review 7.  Tuberous sclerosis: a review for the neurosurgeon.

Authors:  M G Nagib; S J Haines; D L Erickson; A R Mastri
Journal:  Neurosurgery       Date:  1984-01       Impact factor: 4.654

Review 8.  Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: From tuberous sclerosis to common acquired epilepsies.

Authors:  Michael Wong
Journal:  Epilepsia       Date:  2009-10-08       Impact factor: 5.864

9.  Subependymal giant cell astrocytoma: a report of five cases.

Authors:  Raj Kumar; Vinita Singh
Journal:  Neurosurg Rev       Date:  2004-08-12       Impact factor: 3.042

10.  Rapamycin as a therapy of choice after renal transplantation in a patient with tuberous sclerosis complex.

Authors:  A Tarasewicz; A Debska-Slizień; J Konopa; Z Zdrojewski; B Rutkowski
Journal:  Transplant Proc       Date:  2009-11       Impact factor: 1.066

View more
  10 in total

Review 1.  Insights into molecular therapy of glioma: current challenges and next generation blueprint.

Authors:  Y Rajesh; Ipsita Pal; Payel Banik; Sandipan Chakraborty; Sachin A Borkar; Goutam Dey; Ahona Mukherjee; Mahitosh Mandal
Journal:  Acta Pharmacol Sin       Date:  2017-03-20       Impact factor: 6.150

2.  Neurosurgical treatment of subependymal giant cell astrocytomas in tuberous sclerosis complex: a series of 44 surgical procedures in 31 patients.

Authors:  Flavio Giordano; Carla Moscheo; Matteo Lenge; Roberto Biagiotti; Francesco Mari; Iacopo Sardi; Anna Maria Buccoliero; Lorenzo Mongardi; Eleonora Aronica; Renzo Guerrini; Lorenzo Genitori
Journal:  Childs Nerv Syst       Date:  2019-12-18       Impact factor: 1.475

3.  Successful everolimus therapy for SEGA in pediatric patients with tuberous sclerosis complex.

Authors:  A M Cappellano; A A Senerchia; F Adolfo; P M Paiva; R Pinho; A Covic; S Cavalheiro; N Saba
Journal:  Childs Nerv Syst       Date:  2013-06-07       Impact factor: 1.475

Review 4.  Tuberous sclerosis complex: the past and the future.

Authors:  Liesbeth De Waele; Lieven Lagae; Djalila Mekahli
Journal:  Pediatr Nephrol       Date:  2014-12-23       Impact factor: 3.714

5.  Subependymal Giant Cell Astrocytoma (SEGA) Treatment Update.

Authors:  Cynthia J Campen; Brenda E Porter
Journal:  Curr Treat Options Neurol       Date:  2011-08       Impact factor: 3.598

Review 6.  The management of subependymal giant cell tumors in tuberous sclerosis: a clinician's perspective.

Authors:  Romina Moavero; Mariangela Pinci; Roberta Bombardieri; Paolo Curatolo
Journal:  Childs Nerv Syst       Date:  2011-02-09       Impact factor: 1.475

Review 7.  Subependymal giant cell astrocytoma: current concepts, management, and future directions.

Authors:  Taohui Ouyang; Na Zhang; Thomas Benjamin; Long Wang; Jiantong Jiao; Yiqing Zhao; Jian Chen
Journal:  Childs Nerv Syst       Date:  2014-02-19       Impact factor: 1.475

8.  Resection of subependymal giant cell astrocytoma guided by intraoperative magnetic resonance imaging and neuronavigation.

Authors:  Hecheng Ren; Xiaolei Chen; Guochen Sun; Shen Hu; Gang Zheng; Fangye Li; Jinjiang Li; Bainan Xu
Journal:  Childs Nerv Syst       Date:  2013-02-10       Impact factor: 1.475

9.  Current trends in the management of subependymal giant cell astrocytomas in tuberous sclerosis.

Authors:  Paolo Frassanito; Carolina Noya; Gianpiero Tamburrini
Journal:  Childs Nerv Syst       Date:  2020-09-25       Impact factor: 1.475

10.  Novel management of glioma by molecular therapies, a review article.

Authors:  Amin Alinezhad; Fatemeh Jafari
Journal:  Eur J Transl Myol       Date:  2019-08-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.